QUIDELORTHO CORP (QDEL) Fundamental Analysis & Valuation

NASDAQ:QDEL • US2197981051

19.86 USD
-0.97 (-4.66%)
At close: Mar 9, 2026
19.86 USD
0 (0%)
Pre-Market: 3/10/2026, 4:09:01 AM
Overview Stock Chart Technical Analysis Fundamental Analysis Forecast Earnings Financials Ownership News

This QDEL fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

Fundamental Rating

3

Overall QDEL gets a fundamental rating of 3 out of 10. We evaluated QDEL against 184 industry peers in the Health Care Equipment & Supplies industry. QDEL has a bad profitability rating. Also its financial health evaluation is rather negative. QDEL has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

3

1. QDEL Profitability Analysis

1.1 Basic Checks

  • QDEL had positive earnings in the past year.
  • In the past year QDEL had a positive cash flow from operations.
  • In multiple years QDEL reported negative net income over the last 5 years.
  • In the past 5 years QDEL always reported a positive cash flow from operatings.
QDEL Yearly Net Income VS EBIT VS OCF VS FCFQDEL Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 1B -1B -2B

1.2 Ratios

  • QDEL has a Return On Assets of -19.62%. This is comparable to the rest of the industry: QDEL outperforms 51.09% of its industry peers.
  • QDEL has a Return On Equity (-58.93%) which is comparable to the rest of the industry.
  • With a decent Return On Invested Capital value of 0.90%, QDEL is doing good in the industry, outperforming 66.85% of the companies in the same industry.
  • QDEL had an Average Return On Invested Capital over the past 3 years of 1.38%. This is significantly below the industry average of 9.15%.
Industry RankSector Rank
ROA -19.62%
ROE -58.93%
ROIC 0.9%
ROA(3y)-17.23%
ROA(5y)-3.3%
ROE(3y)-42.63%
ROE(5y)-16.05%
ROIC(3y)1.38%
ROIC(5y)9.67%
QDEL Yearly ROA, ROE, ROICQDEL Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 -20 40 -40 60 -60

1.3 Margins

  • Looking at the Operating Margin, with a value of 2.01%, QDEL is in the better half of the industry, outperforming 67.39% of the companies in the same industry.
  • QDEL's Operating Margin has declined in the last couple of years.
  • QDEL's Gross Margin of 46.67% is in line compared to the rest of the industry. QDEL outperforms 42.39% of its industry peers.
  • In the last couple of years the Gross Margin of QDEL has declined.
Industry RankSector Rank
OM 2.01%
PM (TTM) N/A
GM 46.67%
OM growth 3Y-59.4%
OM growth 5Y-49.97%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-7.66%
GM growth 5Y-10.48%
QDEL Yearly Profit, Operating, Gross MarginsQDEL Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50 -50

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

1

2. QDEL Health Analysis

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so QDEL is destroying value.
  • QDEL has more shares outstanding than it did 1 year ago.
  • QDEL has more shares outstanding than it did 5 years ago.
  • Compared to 1 year ago, QDEL has a worse debt to assets ratio.
QDEL Yearly Shares OutstandingQDEL Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M
QDEL Yearly Total Debt VS Total AssetsQDEL Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B 8B

2.2 Solvency

  • QDEL has an Altman-Z score of 0.57. This is a bad value and indicates that QDEL is not financially healthy and even has some risk of bankruptcy.
  • Looking at the Altman-Z score, with a value of 0.57, QDEL is in line with its industry, outperforming 47.83% of the companies in the same industry.
  • QDEL has a Debt/Equity ratio of 1.29. This is a high value indicating a heavy dependency on external financing.
  • QDEL's Debt to Equity ratio of 1.29 is on the low side compared to the rest of the industry. QDEL is outperformed by 77.72% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.29
Debt/FCF N/A
Altman-Z 0.57
ROIC/WACC0.1
WACC8.91%
QDEL Yearly LT Debt VS Equity VS FCFQDEL Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 1B 2B 3B 4B 5B

2.3 Liquidity

  • QDEL has a Current Ratio of 1.50. This is a normal value and indicates that QDEL is financially healthy and should not expect problems in meeting its short term obligations.
  • QDEL has a Current ratio of 1.50. This is in the lower half of the industry: QDEL underperforms 75.54% of its industry peers.
  • A Quick Ratio of 0.90 indicates that QDEL may have some problems paying its short term obligations.
  • Looking at the Quick ratio, with a value of 0.90, QDEL is doing worse than 81.52% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.5
Quick Ratio 0.9
QDEL Yearly Current Assets VS Current LiabilitesQDEL Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. QDEL Growth Analysis

3.1 Past

  • QDEL shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 14.59%, which is quite good.
  • The earnings per share for QDEL have been decreasing by -36.12% on average. This is quite bad
  • QDEL shows a decrease in Revenue. In the last year, the revenue decreased by -1.89%.
  • The Revenue has been growing by 10.44% on average over the past years. This is quite good.
EPS 1Y (TTM)14.59%
EPS 3Y-50.62%
EPS 5Y-36.12%
EPS Q2Q%-26.98%
Revenue 1Y (TTM)-1.89%
Revenue growth 3Y-5.8%
Revenue growth 5Y10.44%
Sales Q2Q%2.23%

3.2 Future

  • Based on estimates for the next years, QDEL will show a quite strong growth in Earnings Per Share. The EPS will grow by 18.94% on average per year.
  • Based on estimates for the next years, QDEL will show a small growth in Revenue. The Revenue will grow by 3.55% on average per year.
EPS Next Y4.37%
EPS Next 2Y19.8%
EPS Next 3Y19.34%
EPS Next 5Y18.94%
Revenue Next Year2.46%
Revenue Next 2Y3.17%
Revenue Next 3Y3.62%
Revenue Next 5Y3.55%

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
QDEL Yearly Revenue VS EstimatesQDEL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 1B 2B 3B
QDEL Yearly EPS VS EstimatesQDEL Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 0 5 10 15

More info and screens

Find the best growth stocksShow best growing peers

5

4. QDEL Valuation Analysis

4.1 Price/Earnings Ratio

  • QDEL is valuated reasonably with a Price/Earnings ratio of 9.37.
  • Based on the Price/Earnings ratio, QDEL is valued cheaply inside the industry as 93.48% of the companies are valued more expensively.
  • The average S&P500 Price/Earnings ratio is at 26.46. QDEL is valued rather cheaply when compared to this.
  • QDEL is valuated reasonably with a Price/Forward Earnings ratio of 8.98.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of QDEL indicates a rather cheap valuation: QDEL is cheaper than 96.74% of the companies listed in the same industry.
  • QDEL's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 24.65.
Industry RankSector Rank
PE 9.37
Fwd PE 8.98
QDEL Price Earnings VS Forward Price EarningsQDEL Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • QDEL's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. QDEL is cheaper than 95.11% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 7.71
QDEL Per share dataQDEL EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30 40

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates QDEL does not grow enough to justify the current Price/Earnings ratio.
  • A more expensive valuation may be justified as QDEL's earnings are expected to grow with 19.34% in the coming years.
PEG (NY)2.14
PEG (5Y)N/A
EPS Next 2Y19.8%
EPS Next 3Y19.34%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. QDEL Dividend Analysis

5.1 Amount

  • No dividends for QDEL!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

QDEL Fundamentals: All Metrics, Ratios and Statistics

QUIDELORTHO CORP

NASDAQ:QDEL (3/9/2026, 8:00:01 PM)

Premarket: 19.86 0 (0%)

19.86

-0.97 (-4.66%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)02-11
Earnings (Next)05-05
Inst Owners123.44%
Inst Owner Change-6.82%
Ins Owners0.5%
Ins Owner Change1.68%
Market Cap1.35B
Revenue(TTM)2.73B
Net Income(TTM)-1.13B
Analysts74.29
Price Target35.87 (80.61%)
Short Float %15.25%
Short Ratio9.33
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)38.64%
Min EPS beat(2)6.57%
Max EPS beat(2)70.71%
EPS beat(4)4
Avg EPS beat(4)198.19%
Min EPS beat(4)6.57%
Max EPS beat(4)691.7%
EPS beat(8)8
Avg EPS beat(8)130.06%
EPS beat(12)10
Avg EPS beat(12)87.81%
EPS beat(16)13
Avg EPS beat(16)76.08%
Revenue beat(2)2
Avg Revenue beat(2)1.67%
Min Revenue beat(2)0.14%
Max Revenue beat(2)3.19%
Revenue beat(4)2
Avg Revenue beat(4)0.07%
Min Revenue beat(4)-1.53%
Max Revenue beat(4)3.19%
Revenue beat(8)5
Avg Revenue beat(8)1.61%
Revenue beat(12)8
Avg Revenue beat(12)1.3%
Revenue beat(16)11
Avg Revenue beat(16)2.09%
PT rev (1m)-6.04%
PT rev (3m)-4.59%
EPS NQ rev (1m)-46.01%
EPS NQ rev (3m)-46.01%
EPS NY rev (1m)-13.49%
EPS NY rev (3m)-18.07%
Revenue NQ rev (1m)-4.22%
Revenue NQ rev (3m)-4.22%
Revenue NY rev (1m)0.18%
Revenue NY rev (3m)-0.07%
Valuation
Industry RankSector Rank
PE 9.37
Fwd PE 8.98
P/S 0.5
P/FCF N/A
P/OCF 12.85
P/B 0.7
P/tB N/A
EV/EBITDA 7.71
EPS(TTM)2.12
EY10.67%
EPS(NY)2.21
Fwd EY11.14%
FCF(TTM)-1.22
FCFYN/A
OCF(TTM)1.55
OCFY7.78%
SpS40.1
BVpS28.21
TBVpS-9.45
PEG (NY)2.14
PEG (5Y)N/A
Graham Number36.68
Profitability
Industry RankSector Rank
ROA -19.62%
ROE -58.93%
ROCE 1.14%
ROIC 0.9%
ROICexc 0.93%
ROICexgc 2.09%
OM 2.01%
PM (TTM) N/A
GM 46.67%
FCFM N/A
ROA(3y)-17.23%
ROA(5y)-3.3%
ROE(3y)-42.63%
ROE(5y)-16.05%
ROIC(3y)1.38%
ROIC(5y)9.67%
ROICexc(3y)1.42%
ROICexc(5y)14.23%
ROICexgc(3y)4.43%
ROICexgc(5y)27.96%
ROCE(3y)1.75%
ROCE(5y)12.24%
ROICexgc growth 3Y-62.81%
ROICexgc growth 5Y-57.09%
ROICexc growth 3Y-55.09%
ROICexc growth 5Y-58.98%
OM growth 3Y-59.4%
OM growth 5Y-49.97%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-7.66%
GM growth 5Y-10.48%
F-Score6
Asset Turnover0.47
Health
Industry RankSector Rank
Debt/Equity 1.29
Debt/FCF N/A
Debt/EBITDA 4.98
Cap/Depr 42.58%
Cap/Sales 6.89%
Interest Coverage 0.32
Cash Conversion 21.18%
Profit Quality N/A
Current Ratio 1.5
Quick Ratio 0.9
Altman-Z 0.57
F-Score6
WACC8.91%
ROIC/WACC0.1
Cap/Depr(3y)43.8%
Cap/Depr(5y)143.82%
Cap/Sales(3y)6.96%
Cap/Sales(5y)8.49%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)14.59%
EPS 3Y-50.62%
EPS 5Y-36.12%
EPS Q2Q%-26.98%
EPS Next Y4.37%
EPS Next 2Y19.8%
EPS Next 3Y19.34%
EPS Next 5Y18.94%
Revenue 1Y (TTM)-1.89%
Revenue growth 3Y-5.8%
Revenue growth 5Y10.44%
Sales Q2Q%2.23%
Revenue Next Year2.46%
Revenue Next 2Y3.17%
Revenue Next 3Y3.62%
Revenue Next 5Y3.55%
EBIT growth 1Y17.85%
EBIT growth 3Y-61.76%
EBIT growth 5Y-44.75%
EBIT Next Year71.5%
EBIT Next 3Y26.64%
EBIT Next 5Y19.95%
FCF growth 1Y25.96%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y26.75%
OCF growth 3Y-50.84%
OCF growth 5Y-30.09%

QUIDELORTHO CORP / QDEL FAQ

Can you provide the ChartMill fundamental rating for QUIDELORTHO CORP?

ChartMill assigns a fundamental rating of 3 / 10 to QDEL.


What is the valuation status for QDEL stock?

ChartMill assigns a valuation rating of 5 / 10 to QUIDELORTHO CORP (QDEL). This can be considered as Fairly Valued.


What is the profitability of QDEL stock?

QUIDELORTHO CORP (QDEL) has a profitability rating of 3 / 10.


What are the PE and PB ratios of QUIDELORTHO CORP (QDEL) stock?

The Price/Earnings (PE) ratio for QUIDELORTHO CORP (QDEL) is 9.37 and the Price/Book (PB) ratio is 0.7.


Can you provide the expected EPS growth for QDEL stock?

The Earnings per Share (EPS) of QUIDELORTHO CORP (QDEL) is expected to grow by 4.37% in the next year.